BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 32873927)

  • 1. Management of brain metastases according to molecular subtypes.
    Soffietti R; Ahluwalia M; Lin N; Rudà R
    Nat Rev Neurol; 2020 Oct; 16(10):557-574. PubMed ID: 32873927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
    Parsai S; Miller JA; Juloori A; Chao ST; Kotecha R; Mohammadi AM; Ahluwalia MS; Murphy ES; Barnett GH; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    J Neurosurg; 2019 Feb; 132(2):503-511. PubMed ID: 30738402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Treatment Options for Breast Cancer Brain Metastases.
    Raghunath A; Desai K; Ahluwalia MS
    Curr Treat Options Oncol; 2019 Feb; 20(3):19. PubMed ID: 30771009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.
    Trino E; Mantovani C; Badellino S; Ricardi U; Filippi AR
    Expert Rev Anticancer Ther; 2017 Apr; 17(4):347-356. PubMed ID: 28277101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melanoma brain metastases : Treatment options].
    Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
    Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
    Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
    J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Chao ST; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    Cancer; 2017 Jun; 123(12):2283-2293. PubMed ID: 28192598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtyping of brain metastases and implications for therapy.
    Renfrow JJ; Lesser GJ
    Curr Treat Options Oncol; 2013 Dec; 14(4):514-27. PubMed ID: 23907440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy.
    Shi DD; Arnaout O; Bi WL; Buchbinder EI; Cagney DN; Insco ML; Liu D; Schoenfeld JD; Aizer AA
    World Neurosurg; 2020 Jul; 139():226-231. PubMed ID: 32330622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic options for brain metastases].
    Preusser M; Winkler F
    Nervenarzt; 2015 Jun; 86(6):716-8. PubMed ID: 25989738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology and therapeutic management of melanoma brain metastases.
    Abate-Daga D; Ramello MC; Smalley I; Forsyth PA; Smalley KSM
    Biochem Pharmacol; 2018 Jul; 153():35-45. PubMed ID: 29278675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy in combination with systemic therapies for brain metastases: current status and progress.
    Liu L; Chen W; Zhang R; Wang Y; Liu P; Lian X; Zhang F; Wang Y; Ma W
    Cancer Biol Med; 2020 Nov; 17(4):910-922. PubMed ID: 33299643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis.
    Kim JM; Miller JA; Kotecha R; Chao ST; Ahluwalia MS; Peereboom DM; Mohammadi AM; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Abraham J; Moore H; Budd GT; Suh JH
    Neuro Oncol; 2019 May; 21(5):659-668. PubMed ID: 30726965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.
    Blake Z; Marks DK; Gartrell RD; Hart T; Horton P; Cheng SK; Taback B; Horst BA; Saenger YM
    J Immunother Cancer; 2018 Apr; 6(1):25. PubMed ID: 29622046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Treatment of Melanoma Brain Metastasis.
    Rishi A; Yu HM
    Curr Treat Options Oncol; 2020 Apr; 21(6):45. PubMed ID: 32350685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases.
    Zafir-Lavie I; Sherbo S; Goltsman H; Badinter F; Yeini E; Ofek P; Miari R; Tal O; Liran A; Shatil T; Krispel S; Shapir N; Neil GA; Benhar I; Panet A; Satchi-Fainaro R
    J Control Release; 2018 Dec; 291():80-89. PubMed ID: 30342077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer.
    Yomo S; Hayashi M; Cho N
    J Neurooncol; 2013 Apr; 112(2):199-207. PubMed ID: 23296546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.